Unspecified GLP-1
Sold by Helimeds · Injection, vial · every unspecified glp-1 record
What you actually pay
Per month
$239
| Medication · Refill (4-week supply, after starter plan) | $239 |
|---|
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| Refill (4-week supply, after starter plan) “Next 4-week supply orders $239.00” | Per month$239 | Charged today$239 |
| EasyStart - 3 months “EasyStart - 3 months SAVE $420 $99 / month” | Per month$99 | Charged today$99 |
| Any dose - 3 month “Any dose - 3 month $199 / month” | Per month$199 | Charged today$199 |
We earn nothing from this link. Helimeds has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
History
One reading so far. A price history appears here after the next verification pass.
- September 2, 2026 — Entry added to the register
Sourcing and terms
| Prescriber | Asynchronous review |
|---|---|
| Cancellation | “What if I need to cancel? To cancel, contact [email protected] . We offer flexible cancellation with no fees or long-term contract commitments.” |
Not yet checked: pharmacy, states, membership and consult fee.
Recorded from helimeds.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2, 2026 — The site's /treatments/semaglutide page is titled 'Compounded GLP-1' and never actually uses the word 'semaglutide' in its visible text, so that product is recorded as unspecified GLP-1 rather than compounded semaglutide -- it does, however, explicitly say the '3 month supply of the medication will arrive in a single vial,' confirming injection-vial. The tirzepatide page never states vial vs pen. Footer branding is 'Travex Inc'; 'Helimeds' is the storefront brand name used throughout the visible copy.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.